Atier

Atier0.3%

Ophthalmic Solution

Hypromellose

ACI Limited

Product Code : 1523
MRP 70.00
10% Off
Best PriceTk
/
1
Section

Medicine overview

Indications of Atier 0.3%

Ophthalmic Solution: Atier 0.3% dye drop is indicated in tear deficiency due to: Impaired lacrimal secretion and Functional disorders as a result of topical or systemic diseases or Caused by deficient or incomplete eyelid closure. Ophthalmic Gel ... Read moreOphthalmic Solution: Atier 0.3% dye drop is indicated in tear deficiency due to: Impaired lacrimal secretion and Functional disorders as a result of topical or systemic diseases or Caused by deficient or incomplete eyelid closure. Ophthalmic Gel: Atier 0.3% enriched with Carbomer 980 is a long-acting eye gel for lubricating the surface of the eye for all patients with ocular discomfort. The slight hypotonicity of the gel is rapidly "neutralized" by the slightly hypertonic tear fluid caused by dry eyes.

Theropeutic Class

Drugs for Dry eyes

Pharmacology

Atier 0.3% is a semisynthetic, inert and viscoelastic polymer used as an ophthalmic lubricant. Atier 0.3% acts as a lubricant and artificial tear in the symptomatic treatment of dehydration of the cornea and conjunctiva due to impaired lacrimal secretion and functional disorders as a result of topical or systemic diseases, or caused by deficient or incomplete eyelid closure.

Dosage & Administration of Atier 0.3%

For adults and children: Therapy of dry eye syndrome requires an individual dosage regimen. The usual dose of 0.3% Atier 0.3% is 1 drop into the conjunctival sac 3 to 5 times per day or as directed by the physician. The dose of 0.5% Atier 0.3% will be different for different patients. Follow your doctor's directions.

Dosage of Atier 0.3%

Ophthalmic Solution: Therapy of dry eye syndrome requires an individual dosage regimen. The usual dose of 0.3% Atier 0.3% is 1 drop into the conjunctival sac 3 to 5 times per day or as directed by the physician. The dose of 0.5% Atier 0.3% will be different for different patients. Follow your doctor's directions. Ophthalmic Gel: Instill 1 or 2 drops in the conjunctival sac of the affected eye(s), as needed. The frequency of administration depends on the severity of the condition. On average, one drop is administered 1-3 times daily. If needed, Atier 0.3% may be administered more frequently.

Interaction of Atier 0.3%

Atier 0.3% can be used in combination with contact lenses. No compatibility study with lens material is available.

Contraindications

Hypersensitivity to this drug or to any ingredient in the formulation or component of the container.

Side Effects of Atier 0.3%

Common side effects are brief blurred vision or a slight stinging sensation on instilling Atier 0.3%. Atier 0.3% enriched with Carbomer 980 is very well tolerated by users. However, some cases of burning, stinging, allergic reactions or red eyes after instillation have been reported. Transient blurring of vision after administration has also been reported.

Pregnancy & Lactation

Atier 0.3% can be used during pregnancy and lactation.

Precautions & Warnings

If eye pains, changes in vision, continued redness or irritation of the eye are noticed Atier 0.3% must be discontinued and a doctor should be consulted. If Atier 0.3% changes color or becomes cloudy, the product should not be used.

Storage Conditions

Store in a cool dry place, away from light. Keep out of reach of children. Do not touch tip of the tube surface since this may contaminate the gel. After one month of the opening do not use the medicine of tube.

Drug Classes

Drugs for Dry eyes

Mode Of Action

Atier 0.3% is a semisynthetic, inert and viscoelastic polymer used as an ophthalmic lubricant. Atier 0.3% acts as a lubricant and artificial tear in the symptomatic treatment of dehydration of the cornea and conjunctiva due to impaired lacrimal secretion and functional disorders as a result of topical or systemic diseases, or caused by deficient or incomplete eyelid closure.

Pregnancy

There is no experience regarding the safety of Atier 0.3% in human pregnancy or lactation. Studies in the pediatric population have not been performed.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.